The global infection surveillance solutions market reached a value of US$ 514.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,158.50 Million by 2027, exhibiting a CAGR of 13.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Infection surveillance solutions assist healthcare personnel in collecting, analyzing, and interpreting data about patients who are suffering from different infections. They notify hospital internet protocol and enable doctors as well as nurses in treating patients by providing dissemination of information. They also help diagnose antibiotic-resistant organisms (AROs), lower respiratory tract infections, and prevent ventilator-associated pneumonia, urinary tract, surgical wound and central line bloodstream. In addition, infection surveillance solutions identify epidemics and offer accurate employee health details, surgical database, real-time medical records, shifts in microbial pathogens.

Infection Surveillance Solutions Market Trends:
The growing prevalence of hospital-acquired infections (HAIs) on account of poor hygienic conditions and negligence by medical staff represents one of the major factors driving the market. Moreover, governments of numerous countries are undertaking initiatives to enhance the quality of care and safety of patients and prevent HAIs. This, along with the rising healthcare expenditure and high adoption rate of improved IT systems in hospitals to maintain electronic healthcare records (EHR), is propelling the growth of the market. In addition, the growing geriatric population and the increasing number of surgeries worldwide are positively influencing the market of infection surveillance solutions. Apart from this, healthcare information and technology (IT) companies are introducing innovative solutions in data management, analytics, and infrastructures that provide convenient data collection of infections and epidemics. This, in confluence with several developments in surveillance solutions to aid medical staff in understanding the software and its usage, is strengthening the market growth. Other factors projected to offer lucrative growth opportunities to key players operating in the market are the increasing adoption of cloud-based software and the escalating demand for web-based solutions and mobile platforms.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infection surveillance solutions market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, deployment type and end user.

Breakup by Component:

Software
Services

Breakup by Deployment Type:

On-premises
Cloud-based

Breakup by End User:

Hospitals
Clinics
Ambulatory Service Centers
Specialty Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter Healthcare, Perahealth Inc., PointClickCare, Premier Inc. and Sunquest Information Systems Inc. (Roper Technologies Inc.). Key Questions Answered in This Report:
How has the global infection surveillance solutions market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global infection surveillance solutions market?
What are the key regional markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the deployment type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global infection surveillance solutions market and who are the key players?
What is the degree of competition in the industry?